News

Business Wire1y
Rallybio Presents Phase 1 Single Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5 - Business Wire
-- Phase 1 Multiple Ascending Dose Study of RLYB116 Ongoing; Preliminary Safety, PK, and PD Data Expected in 4Q 2023 -- September 03, 2023 12:00 PM Eastern Daylight Time ...
Business Wire2y
Evecxia Therapeutics Reports Favorable Data From a Phase 1 Single-Ascending Dose and Multiple-Ascending Dose Trial of Adjunctive EVX-101 in Healthy Volunteers ... - Business Wire
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Evecxia Therapeutics, Inc. today announced favorable safety, tolerability, pharmacokinetic, and pharmacodynamic data from a double-blind, placebo ...
dbta1y
LiquidStack Offers Single-Phase Immersion Cooling Offering for Data Centers - Database Trends and Applications
LiquidStack, a global provider in liquid cooling for data centers, is offering its new single-phase liquid cooling solution, providing data centers with a powerful and economical option to shift from ...